Cryoablation for liver tumors - Is there clinical utility?

MedGenMed Medscape General Medicine

Volumn 5, Issue 4, 2003, Pages

  Subar, Daren A ^a   Sheen, Aali J ^a   Sherlock, David J ^a  

^a PENNINE ACUTE HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; FLUOROURACIL; LIQUID NITROGEN;

ARTICLE; CANCER CONTROL; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RECURRENCE; CANCER SIZE; CANCER SURVIVAL; CHEMOEMBOLIZATION; COLORECTAL CANCER; CRYOTHERAPY; FOLLOW UP; FREEZE THAWING; HUMAN; INTERMETHOD COMPARISON; LIVER CANCER; LIVER CELL CARCINOMA; LIVER METASTASIS; LIVER RESECTION; METASTASIS POTENTIAL; MULTIMODALITY CANCER THERAPY; MULTIPLE ORGAN FAILURE; NEUROENDOCRINE TUMOR; POSTOPERATIVE COMPLICATION; PROGNOSIS; RADIOFREQUENCY ABLATION; SURGICAL MORTALITY; SURVIVAL RATE; SURVIVAL TIME; TREATMENT INDICATION; COLORECTAL TUMOR; CRYOSURGERY; LIVER TUMOR; METASTASIS; METHODOLOGY; MORTALITY; PATHOLOGY; PEROPERATIVE COMPLICATION; REVIEW;

CARCINOMA, HEPATOCELLULAR; COLORECTAL NEOPLASMS; CRYOSURGERY; HEPATECTOMY; HUMANS; INTRAOPERATIVE COMPLICATIONS; LIVER NEOPLASMS; NEUROENDOCRINE TUMORS; POSTOPERATIVE COMPLICATIONS;

EID: 25144479340     PISSN: None     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Weaver ML, et al. Atkinson D, Zemel R, Hepatic cryosurgery in treating colorectal metastases. Cancer. 1995;76:210-214.
2. Zhou XD, Tang ZY, Yu YO, Hou Z. Current management of hepatocellular carcinoma. Hepatogastroenterology. 1991;38:46-55.
3. Rivoire M, DiCian F, Meeus P, Gignoux B, Frering B, Kaemmerlen P. Cryosurgery as a means to improve surgical treatment of patients with multiple unresectable liver metastases. Anticancer Res. 2000;20:3785-3790.
4. Adson MA. Resection of liver metastases - when is it worthwhile? World J Surg. 1987;11:511-520.
5. Cromheecke M, de Jong KP, Hoekstra HJ, Current treatment for colorectal cancer metastatic to the liver. Eur J Surg Oncol. 1999;25:451-463.
6. Sasson AR, Sigurdson ER. Surgical treatment of liver metastases. Semin Oncol. 2002;29:107-118.
7. Oberg K, Eriksson B. The role of interferons in the management of carcinoid tumours. Br J Haematol. 1991;79:74-77.
8. Seifert JK, Junginger T, Morris DL. A collective review of the world literature on hepatic cryotherapy. J R Coll Surg Edinb. 1998;43:141-154.
9. Simmonds PC. Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. Colorectal Cancer Collaborative Group. BMJ. 2000;321:531-535.
10. Kemeny N, Conti JA, Cohen A, et al. Phase II study of hepatic arterial floxuridine, leucovorin, and dexamethasone for unresectable liver metastases from colorectal carcinoma. J Clin Oncol. 1994;12:2288-2295.
11. Bismuth H, Adam R, Levi F, et al. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg. 1996;224:509-520; discussion 520-522.
12. Weber HC, Venzon DJ, Lin JT, et al. Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study. Gastroenterology. 1995;108:1637-1649.
13. Seifert JK, Cozzi PJ, Morris DL. Cryotherapy for neuroendocrine liver metastases. Semin Surg Oncol. 1998;14:175-183.
14. Gage AA. History of cryosurgery. Semin Surg Oncol. 1998;14:99-109.
15. Cooper IS, Hirose T. Application of cryogenic surgery to resection of parenchymal organs. N Engl J Med. 1966;274:15-18.
16. Zhou XD, Tang ZY, Yu YO, Ma ZC. Clinical evaluation of cryosurgery in the treatment of primary liver cancer. Report of 60 cases. Cancer. 1988;61:1889-1892.
17. Ravikumar TS, Kane R, Cady B, et al. Hepatic cryosurgery with intraoperative ultrasound monitoring for metastatic colon carcinoma. Arch Surg, 1987;122:403-409.
18. Cuschieri A, Crosthwaite G, Shimi S, et al.. Hepatic cryotherapy for liver tumors. Development and clinical evaluation of a high-efficiency insulated multineedle probe system for open and laparoscopic use. Surg Endosc. 1995;9:483-489.
19. Neifeld JP. Is cryosurgery appropriate treatment for hepatic malignancies? J Surg Oncol. 1999;70:69-70.
20. Seifert JK, Morris DL. Prognostic factors after cryotherapy for hepatic metastases from colorectal cancer. Ann Surg. 1998;228:201-208.
21. Sotsky TK, Ravikumar TS. Cryotherapy in the treatment of liver metastases from colorectal cancer. Semin Oncol. 2002;29:183-191.
22. Dilley AV, Dy D, Warlters A, et al. Laboratory and animal model evaluation of the Cryotech LCS 2000 in hepatic cryotherapy. Cryobiology. 1993;30:74-85.
23. Midgley R, Kerr D. Colorectal cancer. Lancet. 1999;353:391-399.
24. Leslie A, Steele RJ. Management of colorectal cancer. Postgrad Med J. 2002;78:473-478.
25. Jessup JM, McGinnis LS, Steele GD Jr, Menck HR, Winchester DP. The National Cancer Data Base. Report on colon cancer. Cancer. 1996;78:918-926.
26. Arbuck SG. Overview of clinical trials using 5-fluorouracil and leucovorin for the treatment of colorectal cancer. Cancer. 1989;63:1036-1044.
27. Pedersen IK, Burcharth F, Roikjaer O, Baden H. Resection of liver metastases from colorectal cancer. Indications and results. Dis Colon Rectum. 1994;37:1078-1082.
28. Fong Y, Kemeny N, Paty P, Blumgart LH, Cohen AM. Treatment of colorectal cancer: hepatic metastasis. Semin Surg Oncol. 1996;12:219-252.
29. McCall JL, Booth MW, Morris DL. Hepatic cryotherapy for metastatic liver tumours. Br J Hosp Med. 1995;54:378-381.
30. Ravikumar TS, Steele G Jr, Kane R, King V. Experimental and clinical observations on hepatic cryosurgery for colorectal metastases. Cancer Res. 1991;51:6323-6327.
31. Sheen AJ, Poston GJ, Sherlock DJ. Cryotherapeutic ablation of liver tumours. Br J Surg. 2002;89:1396-1401.
32. Korpan NN. Hepatic cryosurgery for liver metastases. Long-term follow-up. Ann Surg. 1997;225:193-201.
33. Shafir M, Shapiro R, Sung M, Warner R, Sicular A, Klipfel A. Cryoablation of unresectable malignant liver tumors. Am J Surg. 1996;171:27-31.
34. Weaver ML, Ashton JG, Zemel R. Treatment of colorectal liver metastases by cryotherapy. Semin Surg Oncol. 1998;14:163-170.
35. Seifert JK, Morris DL. Indicators of recurrence following cryotherapy for hepatic metastases from colorectal cancer. Br J Surg. 1999;86:234-240.
36. Preketes AP, Caplehorn JR, King J, Clingan PR, Ross WB, Morris DL. Effect of hepatic artery chemotherapy on survival of patients with hepatic metastases from colorectal carcinoma treated with cryotherapy. World J Surg. 1995;19:768-771.
37. Sherman M. Hepatocellular carcinoma. Gastroenterologist. 1995;3:55-66.
38. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med. 1999;340:745-750.
39. Okuda K, Ohtsuki K, Obata H, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer. 1985;56:918-928.
40. Zibari GB, Riche A, Zizzi HC, et al. Surgical and nonsurgical management of primary and metastatic liver tumors. Am Surg. 1998;64:211-220; discussion 220-221.
41. Lai EC, Fan ST, Lo CM, Chu KM, Liu CL, Wong J. Hepatic resection for hepatocellular carcinoma. An audit of 343 patients. Ann Surg. 1995;221:291-298.
42. Bruix J. Treatment of hepatocellular carcinoma. Hepatology. 1997;25:259-262.
43. Wu M, Chen H, Yao X. [Surgical treatment of primary liver cancer]. Zhonghua Wai Ke Za Zhi. 1996;34:707-710.
44. Simonetti RG, Liberati A, Angiolini C, Pagliaro L. Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials. Ann Oncol. 1997;8:117-136.
45. Ravikumar TS, Kane R, Cady B, Jenkins R, Clouse M, Steele G Jr. A 5-year study of cryosurgery in the treatment of liver tumors. Arch Surg. 1991;126:1520-1523; discussion 1523-1524.
46. Little SA, Fong Y. Hepatocellular carcinoma: current surgical management. Semin Oncol. 2001;28:474-486.
47. Poon RT, Fan ST, Tsang FH, Wong J. Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective. Ann Surg. 2002;235:466-486.
48. Zhou XD, Tang ZY. Cryotherapy for primary liver cancer. Semin Surg Oncol. 1998;14:171-174.
49. Wong WS, Patel SC, Cruz FS, Gala KV, Turner AF. Cryosurgery as a treatment for advanced stage hepatocellular carcinoma: results, complications, and alcohol ablation. Cancer. 1998;82:1268-1278.
50. Ihse I, Persson B, Tibblin S. Neuroendocrine metastases of the liver. World J Surg. 1995;19:76-82.
51. Cozzi PJ, Englund R, Morris DL. Cryotherapy treatment of patients with hepatic metastases from neuroendocrine tumors. Cancer. 1995;76:501-509.
52. Wood TF, Rose DM, Chung M, Allegra DP, Foshag LJ, Bilchik AJ. Radiofrequency ablation of 231 unresectable hepatic tumors: Indications, limitations and complications. Ann Surg Oncol. 2000;7:593-600.
53. Curley SA, Izzo F, Delrio P, et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg. 1999;230:1-8.
54. Barnett CC Jr, Curley SA. Ablative techniques for hepatocellular carcinoma. Semin Oncol. 2001;28:487-496.
55. Douillard JY, Cunningham D, Roth AD, et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet. 2000;355:1041-1047.